Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation

The time to complete the screening of a drug submission with a rolling review is 25 days. Once the screening acceptance letter is issued, the review 1 period would begin. The submission would immediately be placed on “rolling review” until Health Canada receives all of the missing information, as indicated in the notice.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Ébauche des lignes directrices sur la gestion des examens en continu des présentations de drogues : Objectifs et normes de rendement, annulation
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2023-01-11 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["présentations de médicaments", "gestion des examens continus", "présentations de médicaments", "objectifs et normes de rendement", "annulation"], "en": ["drug submissions", "management-of-rolling reviews", "drug submissions", "performance targets-and-standards", "cancellation"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source